✦ LIBER ✦

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma

✍ Scribed by Franca Falzetti,Mauro Di Ianni,Stelvio Ballanti…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous Stem Cell Transplantation wit

✍ Gregory M. Cote; Ephraim P. Hochberg; Alona Muzikansky; Fred H. Hochberg; Jan Dr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

High-dose thiotepa, melphalan and carbop

✍ Demirer, T; Ayli, M; Fen, T; Ozcan, M; Arat, M; Buyukberber, S; Arslan, O; Gurma 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Phase II Trial of High-Dose Rituximab wi

✍ Chen, Yi-Bin; Batchelor, Tracy; Hochberg, Ephraim; Brezina, Mark; Coughlin, Erin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Ifosfamide, Idarubicin, and Etoposide in

✍ Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB

High-dose melphalan versus busulfan, cyc

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Multicenter study of intravenous busulfa

✍ Kim, J G; Sohn, S K; Chae, Y S; Yang, D H; Lee, J-J; Kim, H-J; Shin, H J; Jung, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB